Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

Publication
J. Infect. Dis., (215), 9, pp. 1376–1385
Date
Links